'Modest' is a very good word to describe these results.
I think Compass has just inadvertently proved how much value there is in the psychotherapy part of psychedelic medicine, at least when dealing with psilocybin for depression.
psychedelicalpha.com
Psychedelic Alpha’s Josh Hardman reports from Washington, D.C., where conversations with regulators, lawmakers, and insiders suggest a turbulent but potentially transformative period ahead.
